GOSERELIN 3.6mg (Zoladex®)
Zoladex 3.6mg implant is the only licensed product for breast cancer
To be included in the primary care enhanced service for administration
Date of classification
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .